Ra Capital Management, L.P.

EDGAR CIK 0001346824

Tyra Biosciences, Inc. - TYRA

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
4
$33.49 M
2,618,729 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/09/2025
06/11/2025
Buy
186,850 @ $10.19
$1,904,002 10,096,004 (1.89%) Indirect - See footnotes
06/05/2025
06/06/2025
Buy
213,334 @ $10.04
$2,141,873 9,909,154 (2.20%) Indirect - See footnotes
06/04/2025
06/06/2025
Buy
997,864 @ $9.63
$9,609,430 9,695,820 (11.47%) Indirect - See footnotes
11/08/2024
11/13/2024
Buy
1,220,681 @ $16.25
$19,836,066 8,697,956 (16.33%) Indirect - See footnotes

Werewolf Therapeutics, Inc. - HOWL

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
3
$487,188
536,426 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
05/14/2025
05/14/2025
Buy
162,539 @ $0.98
$159,288 6,237,482 (2.68%) Indirect - See footnotes
05/13/2025
05/14/2025
Buy
52,974 @ $0.98
$51,915 6,074,943 (0.88%) Indirect - See footnotes
05/12/2025
05/14/2025
Buy
320,913 @ $0.86
$275,985 6,021,969 (5.63%) Indirect - See footnotes

Mineralys Therapeutics, Inc. - MLYS

Director
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$17.50 M
1,296,296 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/13/2025
03/17/2025
Buy
1,296,296 @ $13.50
$17,499,996 4,280,051 (43.45%) Indirect - See footnotes

Janux Therapeutics, Inc. - JANX

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
4
$79.04 M
2,024,041 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/07/2025
03/07/2025
Buy
110,206 @ $31.02
$3,418,590 10,141,287 (1.10%) Indirect - See footnotes
03/06/2025
03/07/2025
Buy
372,093 @ $30.78
$11,453,023 10,031,081 (3.85%) Indirect - See footnotes
03/05/2025
03/07/2025
Buy
341,742 @ $30.64
$10,471,352 9,658,988 (3.67%) Indirect - See footnotes
10/18/2024
10/22/2024
Buy
1,200,000 @ $44.75
$53,700,000 9,317,246 (14.78%) Indirect - See footnotes

89Bio, Inc. - ETNB

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$50.00 M
5,714,285 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/30/2025
02/03/2025
Buy
5,714,285 @ $8.75
$49,999,994 19,554,319 (41.29%) Indirect - See Footnotes

An2 Therapeutics, Inc. - ANTX

10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($3.81) M
-3,525,094 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/09/2024
08/13/2024
Sell
-3,525,094 @ $1.08
($3,807,102) 300,853 (-92.14%) Indirect - See footnotes

Climb Bio, Inc. - CLYM

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$49.95 M
13,008,546 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2024
07/01/2024
Buy
13,008,546 @ $3.84
$49,952,817 2,866,375 (-128.26%) Indirect - See footnotes

Aerovate Therapeutics, Inc. - AVTE

Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$1.55 M
928,110 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/17/2024
06/20/2024
Buy
928,110 @ $1.67
$1,549,944 7,893,678 (13.32%) Indirect - See footnotes